We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $27B
1-Year Est. Return 24.49%
This Fund
S&P 500
This Quarter Est. Return
+21.7%
1 Year Est. Return
+24.49%
3 Year Est. Return
+88.53%
5 Year Est. Return
+114.58%
10 Year Est. Return
+419.26%
AUM
$10.9B
AUM Growth
+$1.89B
Cap. Flow
+$164M
Cap. Flow %
1.51%
Top 10 Hldgs %
21.79%
Holding
2,159
New
88
Increased
943
Reduced
632
Closed
97

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.4M
2
META icon
Meta Platforms (Facebook)
META
+$13.8M
3
ABBV icon
AbbVie
ABBV
+$10.8M
4
AMZN icon
Amazon
AMZN
+$10.7M
5
GILD icon
Gilead Sciences
GILD
+$9.53M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$18.9M
2
RTN
Raytheon Company
RTN
+$12.4M
3
CB icon
Chubb
CB
+$5.57M
4
MSFT icon
Microsoft
MSFT
+$5.33M
5
PG icon
Procter & Gamble
PG
+$5.19M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 15.34%
3 Financials 12.17%
4 Consumer Discretionary 8.84%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CALA
2001
DELISTED
Calithera Biosciences, Inc
CALA
$6K ﹤0.01%
55
LVGO
2002
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$6K ﹤0.01%
+80
New +$4.19K
IMMU
2003
DELISTED
Immunomedics Inc
IMMU
$6K ﹤0.01%
180
-1,240
-87% -$36.3K
CRUS icon
2004
Cirrus Logic
CRUS
$6.26B
$5K ﹤0.01%
80
-390
-83% -$26.6K
ENPH icon
2005
Enphase Energy
ENPH
$5.53B
$5K ﹤0.01%
110
-580
-84% -$27.7K
LAB icon
2006
Standard BioTools
LAB
$314M
$5K ﹤0.01%
1,335
+275
+26% +$958
MCRB icon
2007
Seres Therapeutics
MCRB
$48.9M
$5K ﹤0.01%
50
PLAY icon
2008
Dave & Buster's
PLAY
$357M
$5K ﹤0.01%
+410
New +$5.46K
PLSE icon
2009
Pulse Biosciences
PLSE
$3.02B
$5K ﹤0.01%
450
WTI icon
2010
W&T Offshore
WTI
$518M
$5K ﹤0.01%
2,200
CBAY
2011
DELISTED
Cymabay Therapeutics
CBAY
$5K ﹤0.01%
+1,400
New +$4.04K
LTRPA
2012
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$5K ﹤0.01%
2,260
+1,060
+88% +$2.42K
PRTK
2013
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5K ﹤0.01%
980
AERI
2014
DELISTED
Aerie Pharmaceuticals
AERI
$5K ﹤0.01%
350
-950
-73% -$14.1K
ABEO icon
2015
Abeona Therapeutics
ABEO
$413M
$4K ﹤0.01%
52
AMSC icon
2016
American Superconductor
AMSC
$1.59B
$4K ﹤0.01%
540
ANIP icon
2017
ANI Pharmaceuticals
ANIP
$1.78B
$4K ﹤0.01%
110
-6,680
-98% -$240K
BJRI icon
2018
BJ's Restaurants
BJRI
$1.48B
$4K ﹤0.01%
210
BUD icon
2019
AB InBev
BUD
$165B
$4K ﹤0.01%
+76
New +$3.55K
GEF.B icon
2020
Greif Class B
GEF.B
$4.21B
$4K ﹤0.01%
100
KZR
2021
DELISTED
Kezar Life Sciences
KZR
$4K ﹤0.01%
74
-280
-79% -$14.1K
PBYI icon
2022
Puma Biotechnology
PBYI
$454M
$4K ﹤0.01%
350
PUK icon
2023
Prudential
PUK
$35.2B
$4K ﹤0.01%
147
+24
+20% +$635
SCOR icon
2024
Comscore
SCOR
$109M
$4K ﹤0.01%
71
+23
+48% +$1.38K
STNG icon
2025
Scorpio Tankers
STNG
$3.81B
$4K ﹤0.01%
350

Similar funds

Nisa Investment Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Nisa Investment Advisors held 2,159 positions worth $10.9B, up 21% from $8.98B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nisa Investment Advisors's Q2 2020 filing shows 88 new, 943 increased, 632 reduced and 97 closed positions. Its largest new stake was Otis Worldwide: 129,485 shares worth $7.36M. The largest sale was Allergan plc, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Nisa Investment Advisors's largest Q2 2020 buy was Otis Worldwide: 129,485 shares worth $7.36M.
  • Nisa Investment Advisors added most to Apple in Q2 2020, an estimated $14.4M increase.
  • Nisa Investment Advisors's biggest Q2 2020 reduction was Chubb, cutting an estimated $5.57M.
  • Nisa Investment Advisors fully exited Allergan plc in Q2 2020, selling an estimated $18.9M.
  • Nisa Investment Advisors's ten largest holdings make up 22% of its $10.9B portfolio in Q2 2020.
  • Nisa Investment Advisors opened 88 new positions and closed 97 in Q2 2020.
  • Nisa Investment Advisors's portfolio value rose 21% quarter-over-quarter to $10.9B.

Based on Nisa Investment Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.